Akanda Corp. (AKAN) vs Decoy Therapeutics Inc. (DCOY)
A side-by-side comparison of Akanda Corp. and Decoy Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AKAN
Akanda Corp.
$1.91HealthcareDelayed quote: Oct 6, 2026, 9:34 AM EDT
DCOY
Decoy Therapeutics Inc.
$1.64HealthcareDelayed quote: Oct 6, 2026, 9:34 AM EDT
Total return — AKAN vs DCOY
growth of $100 · dividends reinvested · last 5yAKAN -100.0% (-91.8%/yr)DCOY -100.0% (-83.3%/yr)DCOY compounded faster over this window
Log scale — wide-divergence pair
AKAN DCOY
AKAN vs DCOY: by the numbers
- •DCOY is the larger company ($872428 vs $61819 market cap).
- •Both run net losses; DCOY's is the smaller (0.00% vs -17690.19% net margin).
Metrics side by side
Valuation
| Metric | AKAN | DCOY |
|---|---|---|
| P/B ratio | N/A | 0.20 |
Profitability
| Metric | AKAN | DCOY |
|---|---|---|
| Gross margin | -60.46% | 0.00% |
| Operating margin | -1930.99% | 0.00% |
| Net margin | -17690.19% | 0.00% |
| ROE | N/A | -334.41% |
| ROIC | -242.09% | -343.55% |
Growth (annualized)
| Metric | AKAN | DCOY |
|---|---|---|
| Revenue CAGR (5Y) | 162.75% | N/A |
| Total return CAGR (5Y) | N/A | -86.39% |
Go deeper
Dig into the metrics
Akanda ROEDecoy Therapeutics ROEAkanda operating marginDecoy Therapeutics operating marginAkanda revenue growthDecoy Therapeutics revenue growthAkanda free cash flowDecoy Therapeutics free cash flow
Akanda & Decoy Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.